PAG
BSX icon

Private Advisor Group’s Boston Scientific BSX Stock Holding History

Private Advisor Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,000
Closed -$1.06K – 2274
2023
Q3 		$1.06K Buy
+2,000
New +$105K ﹤0.01% 2257

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Private Advisor Group's BSX Position: Q1 2026 in Review

Private Advisor Group reduced its Boston Scientific (BSX) stake by 0.28% in Q1 2026, selling an estimated $9.04K and leaving 40,440 shares worth $2.54M. The position accounts for 0.01% of the portfolio, ranked #941.

Private Advisor Group first reported a position in BSX in Q4 2013 and has held it in 48 quarters since. The position peaked at $14.7M in Q3 2021. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Private Advisor Group held 40,440 shares of Boston Scientific worth $2.54M as of Q1 2026.
  • Private Advisor Group sold 113 Boston Scientific shares in Q1 2026, an estimated $9.04K.
  • Boston Scientific made up 0.01% of Private Advisor Group's portfolio in Q1 2026, its #941 holding.
  • Private Advisor Group first reported a position in Boston Scientific in Q4 2013 and has held it in 48 quarters since.
  • Private Advisor Group's Boston Scientific position peaked at $14.7M in Q3 2021.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.